CAS Investment Management
VC Fund
Beijing, China
CAS Investment Management is a VC fund in Beijing focused on Health Care and Manufacturing. CAS Investment Management Co., Ltd. (abbreviated as CASI)' s controlling shareholder is Chinese Academy of Sciences Holdings Co., Ltd. (CAS Holdings www.casholdings.com.cn ) and has State-owned Assets Supervision and Administration Commission of the State Council (SASAC http://www.sasac.gov.cn/n1180/index.html ) and anemployee-owned company as shareholders. Its predecessor is the Chinese National Economic Council-CAS Scientific and Technological Promotion & Economic Development Foundation.With a mission of “providing capital support and value-added service to industrial leaders, and promoting them to be outstanding companies with international competitiveness”, CASI is dedicated to be a Chinese leading PE fund manager.
- Total investments:
- 66
- Last investment:
- Lead investor:
- 39%
Last updated:
For AI agents: llms.txt
Industries CAS Investment Management invests in
Stages CAS Investment Management invests in
Countries CAS Investment Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
2 more contacts available
Investment Focus
Industry
- Health Care 8 (12%)
- Manufacturing 8 (12%)
- Automotive 6 (9%)
- Medical 5 (8%)
- Biotechnology 5 (8%)
Stage
- Series B 12 (18%)
- Series A 9 (14%)
- Series C 4 (6%)
- Funding Round 4 (6%)
- Angel 3 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Jun SHAO
CFO
|
CFO | Total investments: 1 | Find email | |
Qianhong LIU
CEO
|
CEO | Total investments: 0 | Find email | |
|
Sun Hua
Chairman
|
Chairman | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
Orbital Time
|
Orbital Space Technology develops computing satellites launched into dawn-dusk orbits to create space-based data centers. These provide continuous computing power services to customers, leveraging constant sunlight for reliable solar energy and minimal eclipses. | Jun 25, 2026 | |
BioGeometry
|
BioGeo is an innovative digital startup that specializes in using generative AI in protein creation. BioGeo is dedicated to producing programmable proteins from scratch and utilizing them in synthetic biology and biomedicine by employing artificial intelligence-driven techniques to create links between protein sequence, structure, and function. | Seed / Jun 09, 2026 | |
Astribot
|
Astribot is a developer of consumer humanoid robots and integrated bionic robots. | $147.8M / Series B / Jun 03, 2026 | |
HeyGears
|
HeyGears is an innovation-driven technology company with 3D printing applications and digital intelligent manufacturing technologies as its core competencies. The company is dedicated to building a complete service ecosystem by integrating hardware, software, material science, IoT (Internet of Things) and AI (Artificial Intelligence). The ecosystemallows HeyGears to provide B-end customers with whole-chain intelligent manufacturing solutions and offer C-end customers high-quality end products empowered by 3D printing technology.HeyGears aims at building an M-B-C network by utilizing UltraCraft, Ultra-Net, and UltraPrint, and creating new 3D printing application scenarios from “digital production” to “unscaled” retail. The company’s digital manufacturing solutions, services, and business models have and will continuously be applied in health and medical, consumer goods, electronics, and various other industries. HeyGears has customers in more than 10 countries and is continuing to expand globally in America, Europe, and Asia.At HeyGears we encourage innovation and spare no effort to bring the best ideas to life. We empower creative, passionate and purpose-driven people to make a difference. We are committed to a working culture that embraces diversity, promotes equal opportunity and explores possibilities. Your career at HeyGears is defined by you, with a flexible-and-global working environment and your best authentic self. Here we collaborate as an energetic, dynamic and entrepreneurial team. Together we offer the optimal experience to customers, influence the industry with leading digital applications, and help improve the health and lives of our communities. | $44.2M / Series C / May 25, 2026 | |
isheji.com
|
Love Design is an enterprise content creative cloud platform providing online photo editing and graphic design tools for designing. | Series C / May 07, 2026 | |
Moptim
|
Moptim is a global medical technology innovator committed to introduce high technology and ophthalmic product solution at affordable price. | $14.6M / Series B / Apr 08, 2026 | |
New Radiomedicine Technology
|
Chengdu New Radiomedicine Technology Co.,Ltd. is a Chinese medical isotopes provider. Our business covers research, manufacture and sales for medical isotopes and products. We provide services for malignant tumor diagnosis and treatments and radionuclides medicine technology support and consulting.In April 2016, the company was founded bythree co-founders experienced in radionuclides research and development. Jihui Qian, former President of Nuclear Power Institute of China (NPIC), former Deputy Director-General of International Atomic Energy Agency (IAEA); Maoliang Li, former Director of Chengdu Isotopes Institute of NPIC; and Jiming Cai, former Vice President of Sichuan Institute of Atomic Energy.The company is located in Western Airport Development District, Shuangliu, Chengdu, with an area of 71 Are, registered capital of 32.83 million CNY, and total investment of 300 million CNY. The project is listed as "Annual Key Investment Projects of Sichuan Province and Chengdu City in 2017, 2018 and 2019". At present, the company has over 80 employees, with more than 60 R&D specialists, including 1 academician of Chinese Academy of Engineering, 2 experts of Thousand Talent Project, 2 academic and technical leaders from Sichuan province, 10 researchers (associate researchers), and more than 20 people with middle or senior titles. Among them, there are 6 PhDs and over 30 graduates. The proportion of R&D staff has reached 70%, making CNRT the most innovative technology enterprise in the radiopharmaceutical industry in China. | $145.4M / Series E / Apr 03, 2026 | |
Noetix Robotics
|
Noetix Robotics focuses on the development and manufacturing of humanoid robots. | $145.6M / Series B / Mar 02, 2026 | |
|
Yanhe Technology
|
Yanhe Technology provides solar power generation technology-related services. | $14.3M / Series A / Jan 14, 2026 | |
Xinshinuo Semiconductor
|
Xinshinuo Semiconductor is a domestic semiconductor equipment and technology company. | $70.9M / Venture - Series Unknown / Dec 15, 2025 | |
| See all 66 investments → | |||
Co-Investors
Cowin Capital
3 deals together
Fortune Venture Capital
3 deals together
Legend Capital
3 deals together
Legend Star
3 deals together
Temasek
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CAS Investment Management invest in?
CAS Investment Management invests primarily in Health Care, Manufacturing and Automotive startups, most often at Series B and Series A stage. Most of the 66 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CAS Investment Management?
Public channels for CAS Investment Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CAS Investment Management?
The team at CAS Investment Management includes Jun SHAO (CFO), Qianhong LIU (CEO) and Sun Hua (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
